Kisspeptin-10 - Generic Peptides

Buy Kisspeptin-10 by Generic Peptides at XSteroids. Kisspeptin-10 is the briefest active piece of the kisspeptin family, and researchers study it for the way it triggers gonadotropin release. Generic Peptides supplies it as a single 10 mg lyophilized vial. This page covers what the fragment is, the human research on its effect on LH and FSH, how the vial is mixed and what is honestly unknown about using it outside a laboratory.

Kisspeptin-10 is a research peptide and is not approved for medical use anywhere. Nothing on this page is a treatment or dosing recommendation.

What Kisspeptin-10 by Generic Peptides Is and What You Are Buying

The shipment holds a single glass vial of white lyophilized powder, with 10 mg making up everything inside it. Mixing water is not part of the shipment and must be sourced by the buyer, with the powder dissolved before any laboratory use. The substance and the 10 mg figure are what Generic Peptides documents; a filler list and an independent potency check are not published.

KISS1 came to light as a metastasis suppressor gene, and that history explains the older name for the protein it encodes: metastin. The receptor it engages is GPR54, renamed Kiss1R, and the peptide sits inside the RFamide family. A full human peptide runs to 54 amino acids and is trimmed into shorter pieces: kisspeptin-14, kisspeptin-13 and kisspeptin-10, which all share a conserved ten-amino-acid tail. The smallest and best studied of the group is kisspeptin-10.

What you are buying is that fragment in a research format. There is no approved product, no approved indication and no approved dose anywhere in the world.

How Kisspeptin-10 Works

Signals upstream of GnRH

Kisspeptin neurons in the hypothalamus sit above the gonadotropin system. Activating GPR54 increases the release of GnRH, and GnRH in turn drives luteinizing hormone and follicle-stimulating hormone from the pituitary. Because the action is at the top of the chain, the peptide influences the axis rather than replacing one of its hormones. Separately from that chain, it raises aldosterone output from the adrenal cortex, an effect worth flagging.

Reported human data

A controlled study in healthy volunteers found that a bolus of kisspeptin-10 given intravenously lifted serum LH and FSH in men at doses as low as 0.3 and 1.0 nmol/kg. Women responded according to the stage of their cycle: nothing moved in the follicular phase, while the preovulatory phase brought a rise in both hormones. These are findings from controlled research settings, not a dosing protocol.

Very short half-life

After a bolus the reported half-life is only about four minutes, roughly seven times shorter than for full length kisspeptin. Research protocols therefore rely on frequent injections or an infusion instead of one shot, which is also why longer-acting analogues keep attracting interest in the literature.

What to Expect from Kisspeptin-10 Research

The human evidence is short-term and focused on acute hormone release. In the volunteer studies the measurable outcome was a rise in LH and FSH measured in blood within the hours after dosing, with the response depending on sex and cycle stage. There are no long term studies, no data on repeated use in healthy people and no trial that measures whether the peptide restores a suppressed axis over weeks.

That gap is the important part. Anyone reading about kisspeptin-10 as an alternative to HCG should know that the published work maps a short hormonal pulse, not a recovery programme, and the four-minute half-life limits what any single injection can do. Effects on libido, if any, are discussed in the research literature rather than established in controlled trials, so this page makes no claim about them.

Kisspeptin-10 Dosage and Reconstitution

Mixing a kisspeptin-10 vial

Two millilitres of bacteriostatic water in the 10 mg vial gives 5 mg per ml, which sets 1 mg at 0.2 ml, or 20 units on a U-100 insulin syringe, and 0.5 mg at 10 units. One millilitre instead gives 10 mg per ml, so each of those doses occupies half the volume. Introduce the water against the wall of the vial and rotate it; shaking is not the way.

Why the timing matters

Because the reported half-life after an intravenous dose is only about four minutes, research protocols tend to use frequent injections or an infusion rather than a single shot. That short window is one of the practical limits of the peptide and a reason research interest has grown in longer-acting kisspeptin analogues.

What the research used

Published work used nanomole-per-kilogram figures for an intravenous bolus, which do not translate into a marketing dose. Some non-clinical guides talk about 6 to 10 mcg per kg subcutaneously or a flat 100 to 500 mcg per injection, but these are vendor conventions for a research product, not an approved or validated dose.

Stacking Kisspeptin-10 in Research Practice

The interest in this peptide comes from the idea of supporting the body's own gonadotropin signal rather than replacing it. Read about it alongside the direct gonadotropins: HMG 75 IU supplies FSH and LH activity at the testes, and HCG 5000 IU mimics luteinizing hormone at the Leydig cells. Kisspeptin-10 sits above both, at the hypothalamic level. Research in the same catalog also includes PT-141 10 mg and Melanotan II 5 mg in the sexual health line, plus Ipamorelin 5 mg, Sermorelin 5 mg and Somatropin 100 IU on the growth hormone side. No combination with kisspeptin-10 has been formally tested.

Recovery and Post-Cycle Context for Kisspeptin-10

Because kisspeptin-10 acts upstream, some people read about it as an alternative or an addition to HCG when the goal is to encourage the natural axis during recovery. The honest position is that the supportive human data is short-term and focused on acute hormone release, not on restoring a suppressed axis over weeks. There is no established recovery protocol built on this peptide, and the very short half-life limits what a single injection can do.

Kisspeptin-10 Side Effects and Precautions

Reported effects

In the human studies the peptide was generally described as well tolerated at the doses tested. Because it stimulates gonadotropin release, the expected changes are hormonal rather than structural, and the aldosterone effect is a reminder that the peptide touches adrenal signalling as well as the reproductive axis.

What is unknown

There are no long term safety data, no safety data in healthy people using it repeatedly for fitness purposes, and no approved product. Repeated stimulation of the axis with a short-acting peptide is not something the published work has mapped. Anyone reading beyond the research setting is entering territory the data does not cover.

Anti-doping note

There is no published WADA prohibition that names kisspeptin-10 specifically. Because it raises endogenous luteinizing hormone, it would fall under the general reasoning behind the peptide hormone classes, so the accurate statement is that no specific rule is published rather than that the peptide is cleared for sport.

Storage of the Kisspeptin-10 Vial

Store the powder at 2 to 8 C, or move it to a freezer when the holding period is long. Once mixed, the solution stays at 2 to 8 C and is used within about four weeks, and freezing it is something to avoid. No approved label exists for this vial, so what is described here reflects ordinary peptide handling rather than label instructions.

Why Buy Kisspeptin-10 from XSteroids?

Kisspeptin-10 from Generic Peptides arrives as one labelled 10 mg research vial, matching the pack data listed here. Checkout is encrypted, with 3 to 6 days for US domestic delivery and 12 to 26 days internationally. The wording stays honest throughout: no approval exists for this research peptide, and the page never implies otherwise.